Cargando…
Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
A recent randomized controlled trial (RCT), the Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial (REDUCE-IT), reported that high-dose marine omega-3 fatty acids (OM3) significantly reduce cardiovascular disease (CVD) outcomes, yet the mechanisms responsible for this benefit...
Autores principales: | Sekikawa, Akira, Cui, Chendi, Sugiyama, Daisuke, Fabio, Anthony, Harris, William S., Zhang, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893789/ https://www.ncbi.nlm.nih.gov/pubmed/31671524 http://dx.doi.org/10.3390/nu11112599 |
Ejemplares similares
-
Association of blood levels of marine omega-3 fatty acids with coronary calcification and calcium density in Japanese men
por: Sekikawa, Akira, et al.
Publicado: (2018) -
Omega-3 fatty acids in atherosclerosis and coronary artery disease
por: Bäck, Magnus
Publicado: (2017) -
Fatty fish, marine omega-3 fatty acids, and incidence of heart failure
por: Levitan, Emily B., et al.
Publicado: (2010) -
Circulating and Dietary Omega‐3 and Omega‐6 Polyunsaturated Fatty Acids and Incidence of CVD in the Multi‐Ethnic Study of Atherosclerosis
por: de Oliveira Otto, Marcia C., et al.
Publicado: (2013) -
Omega-3 Fatty Acids and Cardiovascular Disease: Are There Benefits?
por: Bowen, Kate J., et al.
Publicado: (2016)